This inventor holds 15 USPTO granted patents, primarily in Genetic Therapies. Top assignees: Leland Stanford Junior University, University of California, Other. Active years: 1998-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
12 out of 5,538 
5 out of 16,082 
2 out of 834,708 Years Active: 1998-2019
Areas of Expertise:
Title: The Innovative Mind of Matthew Peter Scott
Introduction
Matthew Peter Scott, an accomplished inventor based in Stanford, CA, has made significant contributions to the field of biomedical research and treatment. With a remarkable portfolio of 15 patents, Scott's work focuses primarily on innovative methods and compositions for treating serious health conditions, particularly medulloblastoma, a type of brain cancer.
Latest Patents
Among his latest contributions, Scott has developed groundbreaking patents including "Compositions and methods for treating medulloblastoma." This patent details methods for administering a casein kinase II (CK2) inhibitor, specifically CX-4945, to patients with medulloblastoma tumors. The implications of this patent include providing doses sufficient to reduce tumor size and growth rate, ultimately increasing survival rates for individuals affected by this challenging condition.
Another notable patent is "Patched polypeptides and uses related thereto," which presents methods for isolating patched genes associated with human cancers, including basal cell carcinomas. This patent emphasizes the potential for creating transgenic animal models to enhance our understanding of these cancers, allowing for advancements in diagnostic and therapeutic approaches.
Career Highlights
Matthew Peter Scott has had a distinguished career, notably with prestigious institutions such as Leland Stanford Junior University and the University of California. His research has positioned him as a key figure in the realm of cancer biology, contributing to the understanding of gene expression and its relationship with cancer development.
Collaborations
Throughout his career, Scott has collaborated with notable professionals, including Lisa V. Goodrich and Ronald L. Johnson. These partnerships have enabled the fusion of ideas and expertise, fostering innovation in cancer treatment methodologies.
Conclusion
In conclusion, Matthew Peter Scott stands out as an influential inventor whose innovative work continues to impact the field of medicine, particularly in cancer treatment. His patents not only advance scientific understanding but also hold the potential to save lives, showcasing the essential role of inventors in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile